MONTAIR LC KID

Montair LC Kid

Montair LC Kid tablet belongs to a class of drugs called leukotriene receptor antagonists (anti-asthma drugs). Blocks the action of certain natural substances (leukotriene) that cause asthma and allergies. Reduces airway swelling and makes breathing easier.

How does Montair LC kid Work?

Montair LC Kid tablet belongs to a group called bronchodilators. It widens (enlarges) the airways, opens the airways of the lungs, allowing air to pass more freely through the lungs. It can help relieve symptoms such as coughing, wheezing, and shortness of breath, especially in people with asthma at night.

How to take Montair LC Kid

Take the Montair LC Kid tablet for the dosage and duration recommended by your doctor. Please check the instructions on the label before use. Montair LC Kid Tablets can be taken with food, but it’s best to take them on time.

Uses of Montair LC Kid

Allergic rhinitis

Montair LC Kid is used to relieve symptoms such as the runny nose, watery eyes, and sneezing associated with allergic rhinitis. This allergic condition can be seasonal or non-seasonal and last longer.

Asthma and allergic rhinitis

This drug is used to treat asthma and allergic rhinitis that go hand in hand. However, it is not recommended for use in patients with acute and severe asthma attacks.

Side effects

• Difficulty in swallowing
• Pus in urine
• Indigestion
• Skin rash
• Heartburn
• Nausea and Vomiting
• Headache
• Fatigue
• Blurred vision
• Runny Nose
• Dry mouth
• Stomach pain
• Chest tightness
• Joint pain
• Fever
• Cough
• Dizziness
• Diarrhea

Dosage

Missed dose

As soon as possible, take the missed dose. When it’s time for your next dose, skip the missed dose. Don’t take it twice to catch up.

Overdose

In case of overdose, seek emergency treatment or see a doctor.

When not to use

allergy

Montair LC Kid Tablet is not recommended for patients with known allergies to levocetirizine, cetirizine, other piperazine derivatives, montelukast, other leukotriene modifiers, or other inactive ingredients. With this medicine.

Kidney disease

The use of this medicine is not recommended for patients with end-stage renal failure and creatinine clearance below 10 ml/min because of an increased risk of serious side effects. Not recommended for children under 12 years of age with renal impairment.

Galactose intolerance

Montair LC Kid Tablet is not recommended for patients with rare genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption.

General warning

Acute asthma

This drug is not recommended for people with acute or severe asthma attacks.

Changes in behavior and mood

Montair LC Kid tablets can cause changes in behavior and mood. Symptoms such as restlessness, irritability, restlessness, unusual dreams, and suicidal thoughts should be reported to your doctor immediately. Care should be taken when prescribing this drug to people with existing mental health problems. Depending on the clinical condition, it may need to be replaced with an appropriate replacement.

Phenylketonuria

In people with phenylketonuria, this drug should be used with caution as some ingredients in this drug can cause serious side effects. In some cases, depending on the clinical condition, an appropriate dose adjustment or replacement with an appropriate alternative may be required.

Central nervous system depression

May cause mild to moderate central nervous system suppression during treatment with this drug, causing drowsiness, decreased concentration, and more.

Other warnings

This drug may increase your risk of drowsiness and thinking disorder while taking sedatives or sedatives. It is a good idea to tell your doctor about any current medications, including herbs or supplements, before starting treatment with this medication.

Elderly Population

The Tablet should be used with caution in older people because it increases the risk of serious side effects. Adequate dose adjustment may be required depending on the clinical condition.

Use in pediatrics

This drug is not recommended for children under 2 years of age. The safety and effectiveness of use in these patients have not been established.

Urine retention

The tablet should be used with caution in people with spinal cord injury or an enlarged prostate. This can increase the risk of urinary lungs. In some cases, depending on the clinical condition, an appropriate dose adjustment or replacement with an appropriate alternative may be required.

Eosinophil composition conditions

These tablets may rarely cause systemic eosinophilia in some patients with clinical evidence of vasculitis compatible with Churg-Strauss syndrome. Depending on the clinical condition, these patients may require appropriate dosage adjustments or replacement with appropriate alternatives.